Sirolimus as long-term graft-versus-host-disease prophylaxis in haploidentical hematopoietic stem cell transplant recipients for non-malignant disorders is associated with high incidence of acneiform lesions

Sirolimus as long-term graft-versus-host-disease prophylaxis in haploidentical hematopoietic stem cell transplant recipients for non-malignant disorders is associated with high incidence of acneiform lesions

Background: Sirolimus has provided the option for calcineurin inhibitor (CNI)-free immunosuppressive therapy in both solid organ transplant (SOT) and hematopoietic stem cell transplantation (HSCT). However, long-term use of sirolimus has been reported to be associated with a high incidence of cutane...

Full description

Bibliographic Details
Main Authors: Aditi Chakrbarti, Sarita Rani Jaiswal, Suparno Chakrabarti
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Dermatology
Subjects:
Acneiform lesions
aplastic anemia
haploidentical
HSCT
sirolimus
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=6;spage=588;epage=591;aulast=Chakrbarti

Internet

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=6;spage=588;epage=591;aulast=Chakrbarti

Similar Items